p34 cdc2 kinase-phosphorylation sites in the microtubule (MT)-binding region of MAP4 were determined by peptide sequence of phosphorylated MTB3, a fragment containing the carboxy-terminal half of human MAP4. In addition to two phosphopeptides containing Ser696 and Ser787 which were previously indicated to be in vivo phosphorylation sites, two novel phosphopeptides, containing Thr892 or Thr901 and Thr917 as possible phosphorylation sites, were isolated, though only in in vitro phosphorylation. The role of phosphorylation at Ser696 and Ser787, which were differently phosphorylated during the cell cycle (Ookata et al., (1997) . Biochemistry, 36: 15873-15883) , was investigated in MT-polymerization, using MAP4 Ser to Glu mutants, which mimic phosphorylation at each site. Mutation of Ser787 to Glu strikingly reduced the MAP4's MT-polymerization activity, while Glu-mutation at Ser696 did not. These results suggest that Ser787 could be the critical phosphorylation site causing MTs to be dynamic at mitosis.
Microtubules (MTs) are involved in various cellular processes including mitosis, organelle movements and determination of cellular morphology (Hyams and Lloyd, 1993) . MTs are composed of α and β tubulin dimers and a number of microtubule-associated proteins (MAPs). While tubulins are relatively conserved from yeast to human, MAPs vary among species and cell types. Versatile functions of MTs are believed to be conferred by particular MAPs expressed in each tissue or cell. One of the characteristic properties of cytoplasmic MTs is their dynamic behavior, called dynamic instability both in vivo and in vitro; each MT undergoes elongation or shortening repeatedly and independently (Mitchison and Kirschner, 1984; Horio and Hotani, 1986) . The dynamic instability is modulated by structural MAPs that have an ability to polymerize and stabilize MTs (Itoh and Hotani, 1994) . Considering that dynamic properties of MTs change depending on cellular activities, for example during the cell cycle (Belmont et al., 1990; Verde et al., 1990; Faruki and Karsenti, 1994) , the MT-stabilizing activity of MAPs should also be regulated.
Proliferating non-neuronal cells contain MAP4 as the most abundant and most widely distributed MAP (Bulinski, 1993) . These proliferating cells change organization and properties of MTs dramatically at mitosis (see McNally, 1996 for a recent review). Interphase MTs emanating from a centrosome adjacent to the nucleus depolymerize once at the onset of mitosis and reorganize into the mitotic spindle.
Mitotic MTs are more dynamic than interphase MTs; MTturnover increases dramatically in mitosis relative to its level in interphase (Saxton et al., 1984; Hamaguchi et al., 1985) . This dynamic property of mitotic MTs is thought to be caused, at least in part, by the decreased MT-stabilizing ability of MAP4 at mitosis, which could be induced by phosphorylation with p34 cdc2 /cyclin B kinase. MAP4 was shown to be phosphorylated by p34 cdc2 kinase in HeLa cells (Ookata et al., 1997) , and its phosphorylation was shown to reduce MT polymerizing ability in vitro Ookata et al., 1995) . In Xenopus eggs, too, mitotic phosphorylation of a MAP4-like protein (XMAP230 or p220) was shown to participate in mitotic control of MT dynamics (Shiina et al., 1992; Andersen et al., 1994; Faruki and Karsenti, 1994) . To understand the molecular mechanism how MAPs stabilize MTs and how phosphorylation of MAPs modulates their MT-stabilizing activity, the role of each phosphorylation site need to be assigned.
We have shown that MAP4 is phosphorylated in vivo in mitotic HeLa cells at eight sites. Five of these were phosphorylated by p34 cdc2 kinase. Two of the five p34 cdc2 kinase phosphorylation sites were shown to be Ser696 and Ser787 in the proline-rich region (Ookata et al., 1997) . When their phosphorylation states were monitored during the cell cycle with phosphorylation-dependent antibodies, it was found that Ser696 was phosphorylated in interphase as well as at mitosis, while Ser787 was specifically phosphorylated at mitosis. This result suggested that the two phosphorylations might play different roles in MT-organization. In vitro mutagenesis of the phosphorylation site followed by biosynthesis in bacteria would be a suitable method to elucidate their function.
In this paper, we first searched for previously unidentified cdc2 kinase phosphorylation sites within the C-terminal half of MAP4 by peptide sequencing. Thr892 or Thr 901 and Thr917 in the proline-rich region were newly indicated to be possible phosphorylation sites, though only in in vitro phosphorylation. With Ser696 and Ser787 as the primary targets to be examined, we generated MAP4 mutants containing Glu (mimicking phosphorylation) at one or both of Ser696 and Ser787 in E. coli, and examined their abilities to polymerize MTs in vitro. Ser787 was suggested to be a critical phosphorylation site.
Materials and Methods

Preparation of proteins
MTs were prepared from porcine brains by two cycles of temperature-dependent polymerization/depolymerization according to the method of Shelanski et al. (1973) and tubulin (PC-tubulin) was purified by phosphocellulose column chromatography according to Weingarten et al. (1974) . p34 cdc2 /cyclin B kinase, which was purified from starfish oocytes at the first meiotic metaphase using a suc1-column (Okumura et al., 1996) , was provided by Dr. E.
Okumura (Tokyo Institute of Technology).
Preparation of Escherichia coli carrying human full-length MAP4 cDNA or its carboxy-terminal half fragment (MTB3) cDNA was described by Nguyen et al. (1997) . Expression and purification of MTB3 were also described previously (Ookata et al., 1997) . Expression and purification of full-length MAP4 were performed by the same way as MTB3.
Generation of mutant MAP4
Mutation was introduced into human MAP4 cDNA in a PET vector using QuikChangeTM Site-directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's instructions. The following mutagenic primers were used; GGAGCTCCCACCAGACCCAGAGAAGAAAAC for mutating Ser696 to Glu and GAGAAGCGGGCCGCACCATCCAAGC for mutating Ser787 to Glu, along with their complementary primers. Double mutants were prepared by making a second mutation at Ser787 using MAP4 cDNA with a single mutation at Ser696. Mutations were confirmed by DNA sequence of amplified plasmid in XL-1 supercompetent cells. Mutant MAP4 proteins were transformed and expressed in a BL-21 (DE3) strain of E. coli.
Phosphorylation of MAP4 or MTB3 by p34 cdc2 kinase
MAP4 and MTB3 were phosphorylated by p34 cdc2 kinase in 20 mM Pipes, pH 6.8, 5 mM MgCl2, 0.1 mM EGTA, containing 0.1 mM [γ-32 P]ATP at 35°C for 60 min. Reactions were stopped by boiling in the presence of 0.5 M NaCl. After centrifugation at 100,000g for 30 min to precipitate denatured proteins, ATP in the supernatant was removed by gel filtration with a PD-10 column (Pharmacia Biotech, Tokyo, Japan). When phosphorylated proteins were subjected to SDS-PAGE, the reaction was stopped by boiling after addition of an SDS-PAGE sample buffer.
Purification of phosphorylated peptides by HPLC, amino acid sequence and two-dimensional phosphopeptide map analysis
p34 cdc2 kinase-phosphorylated MTB3 was digested by 0.1 unit/ml lysylendopeptidase and applied to a Sephacil C8 reverse phase column (Pharmacia Biotech). Peptides were eluted by an acetonitrile gradient of 0-25% for 120 min and 25-50% for 20 min in the presence of 10 mM ammonium acetate at a flow rate of 0.1 ml/min with a Smart System (Pharmacia Biotech). Fractions containing 32 P were further separated by an acetonitrile gradient of 0-25% in the presence of 0.1% trifluoroacetic acid at a flow rate of 0.1 ml/min with a Sephacil C18 reverse phase column (Pharmacia Biotech). Purified peptides were sequenced with a 477A protein sequencer (Applied Biosystems Japan, Tokyo). 2D phosphopeptide mapping was performed according to Boyle et al. (1991) as described previously (Ookata et al., 1997) .
MT-binding and polymerization assay
Purified MAP4 proteins (0.2 µM) were incubated with MTs (5 µM) polymerized with 20 µM taxol for 30 min at 37°C. After addition of various concentrations of NaCl, MTs were pelleted by centrifugation at 100,000×g for 30 min. The amount of MAP4 in the MT-pellet and the supernatant was analyzed by 7.5% SDS-PAGE followed by image analysis of the gels with NIH image.
MT-polymerization was initiated by incubating PC-tubulin (10 µ M) with wild type or each mutant MAP4 (0.4 µM) at 37°C, and monitored by changes in turbidity at 350 nm in a Beckman DU640 spectrophotometer.
SDS-PAGE, western blotting and protein concentration determination
SDS-PAGE was performed accordingly to Laemmli (1970) . Separated proteins were transferred to Immobilon P membranes (Millipore-Japan, Tokyo, Japan). Blots were probed with antibovine MAP4 antibody, labeled with an alkaline phosphatase conjugated-anti-rabbit IgG (DAKO, Denmark) and developed with a BCIP/NTB phosphatase substrate system.
Results
Phosphorylation sites in the C-terminal half of MAP4, MTB
The carboxy-terminal fragment of human MAP4, named MTB3, constitutes the MT-binding half of the protein, composed of the proline-rich and assembly-promoting domains (Nguyen et al., 1997; Ookata et al., 1997) . We used MTB3 for determination of phosphorylation sites in the C-terminal half of MAP4. MTB3 phosphorylated by p34 cdc2 kinase was digested by lysylendopeptidase and the resulting phosphorylated peptides were purified by sequential chromatography on Sephacil C8 and C18 reverse phase columns. The purified four peptides were sequenced with a peptide sequencer and were shown to correspond to E 692 LPPSPEK 699 , R 785 ASPSK 790 , A 891 TPMPSRPSTTPFIDK 906 , and P 913 SSTTPRLSRLATNTSAPDLK 933 . The first two peptides containing Ser696 and Ser787, respectively, were already shown to be phosphorylation sites and confirmed here by direct sequencing of purified phosphopeptides (Ookata et al., 1997) . The latter two phosphopeptides were novel but they were shown to be in vitro phosphorylation sites by 2D-phosphopeptide map (data not shown). Therefore, these sites were not studied further.
Generation of MAP4 mutants and their binding to MTs
The results described above and those reported previously indicate that Ser696 and Ser787 are the major in vivo phosphorylation sites in the C-terminal half of MAP4. Since they were phosphorylated differently during the cell cycle (Ookata et al., 1997) , their phosphorylation might differentially affect MT-organization. To reveal their respective roles in MT-assembly, we generated mutant MAP4 proteins whose phosphorylation sites were changed to Glu residues; these residues mimic the phosphorylated form (Fig. 1) .
MAP4 proteins were synthesized in E. coli and purified from the heat-stable extract by Mono-S column chromatography. Purified MAP4 proteins migrated at 170kDa on SDS-PAGE, CBB staining and Western blotting with anti-bovine MAP4 are shown in Figure 2 .
The binding ability of Glu mutants of MAP4 to taxol-stabilized MTs is shown in Figure 3 . All mutant MAP4 with Glu at Ser696 and/or Ser787 bound to MTs in the absence of salt as did the wild type MAP4. By increasing salt concentrations, the amount MAP4 released from MTs increased, but there was no difference in NaCl-dependent release among Glu mutants of MAP4 (Fig. 3B ).
MT-polymerization activity of MAP4 mutants whose Ser696 or/and Ser787 were changed to Glu
We investigated the role of phosphorylation at each site in the MT polymerization reaction, by monitoring the turbidity at OD350. The time course of MT polymerization in the presence of MAP4 Glu mutants is shown in Figure 4A . Similar results were obtained with three different preparations of mutant MAP4. We also confirmed formation of MTs with each mutant of MAP4 by negative staining electron microscopy (data not shown). In the absence of MAP4, MTs did not assemble at the tubulin concentration used (Fig. 4A, ) . Wild type MAP4 expressed in E. coli was capable of polymerizing MTs ( ) and its phosphorylation by p34 cdc2 kinase reduced MT-polymerization ( ), as previously reported for MAP4 prepared from HeLa cells Ookata et al., 1995) . The Glu mutant at Ser696 (MAP4 S696E ) showed a slightly higher turbidity increase compared to wild type MAP4 ( ). Though this higher turbidity was slight, it was reproducible. The Glu mutant at Ser787 (MAP4 S787E ) showed a much decreased polymerization of MTs ( ); it decreased polymerization even more than wild type MAP4 that had been phosphorylated by p34 cdc2 kinase. Polymerization activity of the double mutant at both Ser696 Fig. 1 . Schematic representation of mutant MAP4 molecules. MAP4 is divided into four distinct functional domains; the amino-terminal projection domain (NR), proline-rich region (Pro, hatched) being able to bind to MTs, the assembly promoting region (AP, striped) composed of three to five repetitive 18 amino acid sequences, and the extreme carboxyterminal domain (C). p34 cdc2 kinase phosphorylation sites determined in this study are indicated at the top. Ser residues at in vivo phosphorylation sites of 696 and 787 were mutated to Glu for mimicking phosphorylation. and 787 (MAP4 S696/787E ) ( ) was similar to that of the single mutant at Ser787 ( ).
The final extent and initial increase of turbidity change are summarized in Figure 4B and C, respectively. The effect of Ser to Glu exchange appeared to be more significant on the assembly rate than on the polymerization extent, although they showed a similar tendency. These results indicate that phosphorylation at Ser787, but not Ser696, is sufficient to reduce the MT-polymerization activity of MAP4.
Discussion
In this paper, we confirmed Ser696 and Ser787 to be the major phosphorylation sites in the C-terminal half of MAP4 by peptide sequence, and we investigated their respective roles in MT-polymerization with recombinant MAP4 mutants in vitro. We found that MAP4 with Glu-mutation at each of these two phosphorylation sites had different effects on MT-polymerization; phosphorylation at Ser787, but not at Ser696, appeared to be sufficient to reduce the MT-polymerizing ability of MAP4.
MAP4 is phosphorylated at mitosis in cultured mammalian cells Vandre et al., 1991; Ookata et al., 1997) and phosphorylation of MAP4 by p34 cdc2 kinase has been shown to reduce the MT-polymerization activity in vitro Ookata et al., 1995) . Because the MT-binding activity is localized in the C-terminal half of MAP4, it is reasonable to assume that phosphorylation in this region plays an important role in the regulation of MTassembly. In a previous study using both recombinant MAP4 C-terminal fragments and phosphorylation-dependent antibodies (Ookata et al., 1997) , we identified that Ser696 and Ser787 in the proline-rich region are the in vivo phosphorylation sites. In this study we confirmed it by peptide sequence, which indicated that Ser696 and Ser787 are the primary targets to be examined for their roles in MTassembly.
In vitro mutation of Ser into Asp, an amino acid mimicking phosphorylation, has recently been used to elucidate the role of site specific phosphorylation in tau with a similar molecular structure to MAP4. Leger et al. (1997) reported that double mutation at Ser156 and Ser327 of fetal human tau (corresponding to amino acids Ser214 and Ser416 of longest human tau isoform) to Asp drastically decreased the nucleation activity of MTs while a single mutation at Ser327 affected only conformation. Although neither Ser156 nor Ser327 of tau has been demonstrated to be an in vivo phosphorylation site, in vitro phosphorylation of these individual sites appears to have a distinct role in modulation of structural MAP function. We adopted the same strategy of in vitro mutation of Ser to Glu (also mimicking phosphorylation) to investigate the roles of two in vivo phosphorylation sites of MAP4.
Very recently, Shiina and Tsukita (1999) reported that phosphorylation by p34 cdc2 kinase is responsible for the reduced MT-binding ability of Xenopus MAP4 during mitosis using unphosphorylatable Ala mutation and their transfection into cultured cells. Because multiple p34 cdc2 kinase phosphorylation sites were mutated to Ala at one time, however, the site-specific role of each phosphorylation site is still unknown. Here, we have shown that the mutation at a single site of Ser787 to Glu dramatically decreased MT polymerization activity of MAP4. To our surprise, the effect was more striking than we thought. MAP4 S787E showed less activity to stimulate MT-polymerization than wild type MAP4 phosphorylated by p34 cdc2 kinase. Thus, phosphorylation of Ser787 appeared to be greatly involved in reducing the MT-polymerization activity of MAP4. Taken together, Ser787 is the only mitosis-specific p34 cdc2 kinase phosphorylation site in the C-terminal half of MAP4 (Ookata et al., 1997) , phosphorylation at Ser787 by p34 cdc2 kinase could be a major mechanism that induces the greater dynamics of mitotic MTs (McNally, 1996) .
On the other hand, exchange of Ser696 to Glu did not contribute detectably to the reduction in MT-polymerizing ability; instead, it seemed to enhance polymerization slightly. This result was unexpected; our initial idea was that phosphorylation at Ser696 would also decrease the MT-sta- bilizing ability of MAP4 to some extent. However, the present result correlates well with the fact that Ser696 is phosphorylated during interphase.
In spite of their localization in the proline-rich domain, why might phosphorylation at these two sites display different effects on MT-polymerization? MAP4 is a flexible filamentous molecule with no obvious secondary structure (Woody et al., 1983; Murofushi et al., 1986) . Phosphoryla- tion may change chemical properties within the primary structure rather than secondary structure. The proline-rich region was originally identified as a region rich in proline, serine and basic amino acids (Aizawa et al., 1990) ; later this region was shown to bind strongly to MTs . West et al. (1991) suggested that this region could be further subdivided into a highly proline-rich conservative domain (P) and a region containing clusters of proline and serine (S, P). Figure 5 shows the acidicity-basicity of the proline-rich region from amino acid residues 600 to 850 of human MAP4; this region contains the two phosphorylation sites. Ser787 is within the basic S,P domain, and it is feasible that phosphorylation at this site weakens ionic interactions between this basic region of MAP4 and the acidic region of tubulin. The S 787 PSK sequence is conserved among mammalian MAP4 species sequenced thus far. Phosphorylation at this site might be important for reducing MT dynamics at mitosis. In contrast, Ser696 in the N-terminal site of the proline-rich domain constitutes the border between the N-terminal acidic region and the C-terminal basic region. Phosphorylation of Ser696 results in a shift of the border toward the C-terminal site as shown schematically in Figure 5 . This difference may explain the different effect of phosphorylation on Ser696, as compared to Ser787. Dephosphorylation at Ser696 was induced in HeLa cells and human fibroblasts by serum depletion (Sršen et al., 1999) , which is also shown to induce destabilization of MTs (Gundersen et al., 1994) . Phosphorylation of Ser696 may play a role in modulation of MAP4 activity in serum-dependent MT stabilization. It will be interesting to investigate the effect of Glu-mutation at Ser696 of MAP4 in MT stabilization in more detail, particularly because the entire amino acid sequence around Ser696 is conserved evolutionarily, from chicken MAP4 to human MAP4 (Aizawa et al., 1990; West et al., 1991; Chapin et al., 1995; Stassen et al, 1996; Shiina et al., 1999) . Fig. 5 . Effect of phosphorylation on acidicity-basicity of MAP4. Scores of +1, +0.5, −1, −2, and 0 were given to Lys and Arg, His, Asp and Glu, phosphorylated Ser, and other amino acid residues, respectively. The mean of the scores of 21 amino acids (residues X-10 to X+10) is plotted against a residue number X from amino acid residue 600 to 850 of human MAP4. Dotted line represents the acidicity-basicity changed by phosphorylation.
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